Atai Life Sciences Total Liabilities 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Atai Life Sciences total liabilities from 2020 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Atai Life Sciences Total Liabilities 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Atai Life Sciences total liabilities from 2020 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$21.4B
Quest Diagnostics (DGX)	$17.3B
DaVita (DVA)	$13.8B
Encompass Health (EHC)	$9.2B
Chemed (CHE)	$8.7B
Elanco Animal Health (ELAN)	$7.1B
Option Care Health (OPCH)	$5.3B
RadNet (RDNT)	$4.9B
Amedisys (AMED)	$3.2B
Astrana Health (ASTH)	$2.7B
LifeStance Health (LFST)	$2.6B
Addus HomeCare (ADUS)	$2.4B
U.S Physical Therapy (USPH)	$1.3B
Pennant (PNTG)	$1B
Aveanna Healthcare Holdings (AVAH)	$1B
Daxor (DXR)	$46M
ATI Physical Therapy (ATIP)	$26M
MEDIROM Healthcare Technologies (MRM)	$19M
Psychemedics (PMD)	$14M
Ontrak (OTRK)	$10M
Novo Integrated Sciences (NVOS)	$5M
IMAC Holdings (BACK)	$2M